LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $242,000 | +11.0% | 1,566 | 0.0% | 0.04% | 0.0% |
| Q3 2021 | $218,000 | +6.3% | 1,566 | 0.0% | 0.04% | +5.9% |
| Q2 2021 | $205,000 | -14.2% | 1,566 | 0.0% | 0.03% | -22.7% |
| Q1 2021 | $239,000 | +12.2% | 1,566 | 0.0% | 0.04% | -30.2% |
| Q4 2018 | $213,000 | -50.5% | 1,566 | 0.0% | 0.06% | -41.7% |
| Q3 2018 | $430,000 | +32.7% | 1,566 | 0.0% | 0.11% | +25.6% |
| Q2 2018 | $324,000 | +51.4% | 1,566 | 0.0% | 0.09% | +45.8% |
| Q4 2017 | $214,000 | +5.9% | 1,566 | -6.0% | 0.06% | +3.5% |
| Q2 2017 | $202,000 | -1.0% | 1,666 | -16.6% | 0.06% | -19.7% |
| Q3 2016 | $204,000 | -14.3% | 1,998 | 0.0% | 0.07% | -16.5% |
| Q2 2016 | $238,000 | +11.2% | 1,998 | 0.0% | 0.08% | +3.7% |
| Q1 2016 | $214,000 | -1.4% | 1,998 | 0.0% | 0.08% | -7.9% |
| Q4 2015 | $217,000 | -33.8% | 1,998 | -81.0% | 0.09% | -41.8% |
| Q1 2015 | $328,000 | – | 10,530 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |